Opaganib

Opaganib is an orally available, aryladamantane compound and selective inhibitor of sphingosine kinase-2 (SK2) with potential antineoplastic activity. Upon administration, opaganib competitively binds to and inhibits SK2, thereby preventing the phosphorylation of the pro-apoptotic amino alcohol sphingosine to sphingosine 1-phosphate (S1P), the lipid mediator that is pro-survival and critical for immunomodulation. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Yeliva, opaganibum and 4-pyridinylmethyl-3-(4-chlorophenyl) adamantane carboxamide. Its PubChem CID is 15604015.

CAS No 915385-81-8
Molecular Formula C23H25ClN2O
Molecular Weight 380.9 g/mol
Synonyms 3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide

Frequently Asked Questions